Generation Bio Co expected to post a loss of 50 cents a share - Earnings Preview

Generation Bio

30/10/2023 13:14

* Generation Bio Co  GBIO.OQ   GBIO.O  is expected to show a
rise
in quarterly revenue when it reports  results 
    * The Cambridge Massachusetts-based  company is expected to
report
revenue of $1.093 million, according to the mean estimate from 7
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Generation Bio Co
is for
a loss of 50 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Generation
Bio Co
is $11​, above​ its last closing price of $0.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.50       -0.50      -0.47     Beat    5.4
 Mar. 31 2023  -0.45       -0.46      -0.53     Missed  -14.2
 Dec. 31 2022  -0.58       -0.58      -0.55     Beat    5​
 Sep. 30 2022  -0.66       -0.67      -0.53     Beat    21.1
 ​​Jun.        -0.63       -0.62      -0.66     Missed  -6
 30 2022                                                
 Mar. 31 2022  -0.53       -0.52      -0.61     Missed  -16.2​
 Dec. 31 2021  -0.58       -0.57      -0.54     Beat    5.3
 Sep. 30 2021  -0.56       -0.56      -0.56     Met     -0.6
 This summary was machine generated October 30 at 13:14 GMT.  All
figures in US dollars  unless otherwise stated